Last but not least, for the other tumor such as glioblastoma multiforme, lung cancers, and pancreatic ductal adenocarcinoma, ROS, and RNS could activate the apoptosis of the tumor and accelerate the release of the necrosis factors related to MAPK or NF-κB signaling pathways to inhibit tumors. This evidence concerns the gene NFKB1 and lung carcinoma.